Bottom line
Is PHSTX a good fund? The bottom line
PHSTX is the Class A share class of Putnam Global Health Care Fund, an actively managed health care sector mutual fund from Franklin Templeton.
Annual fees run 1.04% — about $104 a year on every $10,000 invested, more expensive than 56% of health care sector funds we track.
It returned −4.6% over one year, +6.5% a year over five years, +6.9% a year over ten (as of Dec 31, 2024, per its prospectus).
With $1.5 billion in net assets and 115 holdings, its largest position is Eli Lilly & Co. (13.1%) and the top 10 make up 61.1% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
The closest lower-cost alternative we found is XLV (0.08%, 67% top-holdings overlap).
What stands out
- 5-year return beat 78% of category peers
What to watch
- Concentrated: top 10 holdings are 61.1% of assets
- Front-end sales load up to 5.75%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What PHSTX invests in
The fund seeks capital appreciation.
As a non-diversified fund concentrating in the health care industries, the fund invests mainly in common stocks (growth or value stocks or both) of large and midsize companies worldwide that the Investment Manager, as defined below, believes have favorable investment potential. Under normal circumstances, the fund invests at least 80% of its net assets in securities of companies in the health care industries. This policy may be changed only after 60 days notice to shareholders. Potential investments include companies that manufacture health care supplies or provide health care-related services, and companies in the research, development, production and marketing of pharmaceuticals and biotechnology products. The fund may purchase stocks of companies with stock prices that reflect a value lower than that which that Investment Manager places on the company. The Investment Manager may…
From the fund's prospectus (filed Dec 23, 2025).
PHSTX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| PHSTX | −4.6% | +6.5% | +6.9% |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2024
What PHSTX costs
On a $10,000 investment, PHSTX's 1.04% expense ratio costs about $104 a year. The prospectus estimates $1,772 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
PHSTX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Eli Lilly & Co. | 13.15% |
| 2 | Johnson & Johnson | 8.46% |
| 3 | UnitedHealth Group, Inc. | 6.93% |
| 4 | AbbVie, Inc. | 6.05% |
| 5 | Novartis AG | 5.13% |
| 6 | Merck & Co., Inc. | 4.88% |
| 7 | AstraZeneca plc | 4.67% |
| 8 | Thermo Fisher Scientific, Inc. | 4.50% |
| 9 | Intuitive Surgical, Inc. | 4.04% |
| 10 | Sanofi SA | 3.23% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 61.1% of the fund. See all top 25 holdings and asset mix →
Alternatives to PHSTX
| Family | Fund | Expense ratio | Overlap | |
|---|---|---|---|---|
| SPDR (State Street) | XLV State Street(R) Health Care Select… | 0.08% | 67% | Compare |
| Fidelity | FHLC Fidelity MSCI Health Care Index ETF | 0.084% | 67% | Compare |
| Vanguard | VHT Vanguard Health Care Index Fund | 0.09% | 67% | Compare |
| iShares | IXJ iShares Global Healthcare ETF | 0.38% | 78% | Compare |
| J.P. Morgan | JDOC JPMorgan Healthcare Leaders ETF | 0.65% | 64% | Compare |
| Schwab | SWHFX Schwab Health Care Fund | 0.8% | 64% | Compare |